8 PrEP Myths That Keep People From Starting

Myth 1: "PrEP is only for gay men"

Reality: CDC describes PrEP as medicine for adults and adolescents without HIV who may be exposed to HIV through sex or injection drug use. That includes straight men and women, trans and nonbinary people, people with a partner who has HIV, and people who inject drugs.

Some options fit some people better. Generic Truvada (F/TDF) and both injectables, Apretude and Yeztugo, are approved for people exposed through vaginal sex. Descovy is not indicated for people at risk from receptive vaginal sex. Our guides to PrEP for women and PrEP for transgender women walk through the choices.

Myth 2: "You have to prove you're high-risk"

Reality: CDC's clinical guidance tells clinicians, in so many words, to "prescribe PrEP to anyone who asks for it."

You don't have to list partners or describe what you do in bed to justify a prescription. A clinician may ask questions to pick the right option and the right tests, and you can share what you're comfortable sharing. If a provider brushes you off, that's a reason to find another one. Our doctor-conversation guide includes a script.

Myth 3: "PrEP wrecks your kidneys"

Reality: For most people, it doesn't. Tenofovir disoproxil fumarate (TDF), the drug in Truvada and its generics, can cause a small decline in kidney function in some people. Here's what's actually true:

• The changes are usually small and generally reverse after stopping.
• Oral PrEP comes with routine kidney checks so problems are caught early. CDC calls for at least yearly checks, and every 6 months for people 50 and older.
• Truvada's label says it isn't recommended for PrEP when kidney function (creatinine clearance) is below 60 mL/min. People in that range have other options.
• Descovy (F/TAF) is easier on kidneys and bones. CDC doesn't require kidney monitoring for injectable cabotegravir.

One thing worth knowing: Truvada's label warns against combining it with high-dose or multiple NSAID painkillers, like ibuprofen or naproxen, because of kidney risk. Mention regular painkiller use to your prescriber. For the full data, see is PrEP safe long-term?

Bones get a similar worry. TDF can cause a small drop in bone mineral density, which is why some prescribers prefer Descovy or an injectable for teens still building bone or for older adults at risk of osteoporosis. Descovy has its own trade-off: it's associated with modest weight gain in some people. Every option has a profile, and part of a prescriber's job is matching you to the right one.

Myth 4: "PrEP is too expensive"

Reality: The list price is high, but very few people pay it. Most private plans have to cover PrEP with no cost sharing as a preventive service. Medicaid covers it. Manufacturer assistance programs help people who are uninsured. Several telehealth services and community clinics provide PrEP at no cost. We explain each route on our free PrEP page and in why your insurance owes you free PrEP.

If you're uninsured, you still have routes. Gilead's and ViiV's patient assistance programs, community health centers that serve everyone regardless of insurance, and state PrEP programs in some states all exist for this situation. Our free PrEP guide lays them out.

Myth 5: "Taking PrEP means you're reckless"

Reality: Taking PrEP is a health decision, like using birth control or getting vaccinated. People start PrEP for many reasons: a partner with HIV, living somewhere HIV is common, sex work, injecting drugs, wanting peace of mind, or simply being single and dating. None of those reasons need a moral judgment.

It's true that PrEP doesn't prevent other STIs, and CDC says so plainly. That's why PrEP care includes regular STI testing, which means many people on PrEP get tested more often than they did before. Our sister site explains the STI testing schedule that comes with PrEP. Condoms still help prevent other STIs and pregnancy, and you can use both.

Myth 6: "PrEP works the moment you take it, and it's 100%"

Reality: PrEP is one of the most effective prevention tools there is, but it isn't magic.

• NIH says PrEP reduces the risk of getting HIV from sex by about 99% when taken as prescribed. For injection drug use, PrEP pills reduce risk by as much as 74%.
• Daily pills take time to build up. CDC says maximum protection takes about 7 days for receptive anal sex and about 21 days for receptive vaginal sex and injection drug use.
• Missing doses lowers protection. If adherence is hard, a long-acting shot may fit better.

One more limit: you need a negative HIV test before you start, and regular tests while you're on it. Taking PrEP with an undiagnosed HIV infection can lead to drug resistance, which is why every option's label requires testing. It's a quick blood draw or an at-home kit, depending on your provider.

Overstating PrEP doesn't help anyone. Knowing these limits is what makes it work.

Myth 7: "PrEP messes with birth control or hormones"

Reality: CDC's clinical guidance says there are no known drug interactions between PrEP and hormonal contraception. You can use both at the same time. For gender-affirming hormones, research hasn't found that estrogen meaningfully lowers PrEP drug levels or that PrEP affects feminizing hormones, as our trans women's PrEP guide explains. Always give your prescriber a full list of what you take, including supplements, so they can check for real interactions.

Myth 8: "Once you start PrEP, you're on it for life"

Reality: PrEP is for the seasons of your life when HIV exposure is possible. People start, stop and restart all the time. The only rules are to stop with a plan, because daily pills need to continue for a while after your last exposure and hepatitis B needs special care, and to get an HIV test before restarting. Our long-term safety guide covers what stopping means for your body.

This guide is general health information, not medical advice, and it doesn't replace a conversation with a clinician who knows your history. Guidance and program rules change; we last reviewed this page on October 12, 2026. Spot something out of date? Tell us.